Compare Allstate Corp (ALL) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs Lam Research Corporation — how do they compare? Allstate Corp trades at $260.5 (market cap $64.69B), while Lam Research Corporation trades at $332.63 (market cap $408.07B). The key difference: Lam Research Corporation is far larger — about 6.3× Allstate Corp's market cap, and Allstate Corp pays the higher dividend (1.69%). Which is the better fit depends on your goals.
| ALL | LRCX | |
|---|---|---|
Market Cap | $64.69B | $408.07B |
Sector | Financials | Technology |
52-Week High | $275.11 | $433.33 |
52-Week Low | $190.00 | $97.03 |
Enterprise Value | $73.34B | $406.22B |
Dividend Yield | 1.69% | 0.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Allstate (ALL) trades at $260.48, down 0.67% on the day, with a bullish fundamental backdrop highlighted by strong earnings beats and robust profitability. The stock shows a bearish technical signal but is supported by a consensus price target of $266.47. Recent results demonstrate a significant turnaround, with net income surging to $10.28 billion in 2025 from a loss in 2022, driven by improved underwriting and investment income.
The outlook is positive given earnings momentum and shareholder returns via dividends, but sustainability of peak profitability and competitive pressures pose risks. Analyst sentiment is mixed with a majority hold rating, reflecting caution despite solid fundamentals. Upside potential exists if operational strength continues, though macroeconomic and industry-specific headwinds require monitoring.
Lam Research (LRCX) trades at $337.01, up 8.22% over 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with consistent earnings beats and robust fundamentals, including a 29.06% net income margin and 65.07% ROE. Recent news highlights a $3 billion R&D expansion plan to capitalize on AI-driven semiconductor demand, reinforcing growth prospects amid positive analyst sentiment.
Outlook remains favorable with a consensus price target of $397.18, though elevated valuation ratios (P/E of 56.62) and cyclical semiconductor risks warrant caution. The company's strategic investments and earnings trajectory support upside potential, but investors should monitor industry volatility and execution of growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
